Incidence and Risk Factor of Post-ERCP Pancreatitis in Chronic Pancreatitis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02781987|
Recruitment Status : Completed
First Posted : May 25, 2016
Last Update Posted : January 13, 2017
|Condition or disease||Intervention/treatment|
|Post-ERCP Acute Pancreatitis||Other: chronic pancreatitis|
|Study Type :||Observational|
|Actual Enrollment :||2028 participants|
|Observational Model:||Case Control|
|Official Title:||Changhai Hospital, the Second Military Medical University|
|Study Start Date :||January 2011|
|Actual Primary Completion Date :||May 2015|
|Actual Study Completion Date :||May 2015|
Those patients with chronic pancreatitis underwent ERCP for pancreatic stone clearance, pancreatic stent placement, etc..
Other: chronic pancreatitis
patients with chronic pancreatitis
Those patients with biliary ductal disease, such as choledocholithiasis, underwent ERCP to relieve outflow obstruction of the common bile duct.
- Numbers of chronic pancreatitis patients with post-ERCP pancreatitis, diabetes mellitus, steatorrhea, previous pancreatitis, previous PEP, pancreatic divisum, jaundice, ESWL, pancreatic duct stone, drainage and minor papilla pancreatogram. [ Time Frame: 8 months ]
- Numbers of biliary disease patients with post-ERCP pancreatitis, previous pancreatitis and previous PEP. [ Time Frame: 2 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02781987
|Study Chair:||Zhao-shen Li||Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|